Comparison of Haploidentical Bone Marrow versus Matched Unrelated Donor Peripheral Blood Stem Cell Transplantation with Post-transplant Cyclophosphamide in Patients with Acute Leukemia.
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Nagler A
- Labopin M
- Dholaria B
- Angelucci E
- Afanasyev B
- Cornelissen JJ
- Sica S
- Meijer E
- Ciceri F
- Van Gorkom G
- Kröger N
- Martin H
- Pioltelli P
- Risitano A
- Canaani J
- Savani BN
- Mohty M
Grupos
Abstract
Post-transplant cyclophosphamide (PTCy) is increasingly being utilized as a principle graft-versus-host disease (GvHD) prophylaxis strategy in allogeneic hematopoietic cell transplantation (allo-HCT). A haploidentical (haplo) or matched unrelated donor (UD) are valid options in the absence of a matched related donor.
Datos de la publicación
- ISSN/ISSNe:
- 1078-0432, 1557-3265
- Tipo:
- Article
- Páginas:
- 843-851
- PubMed:
- 33148668
- Factor de Impacto:
- 5,427 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
CLINICAL CANCER RESEARCH AMER ASSOC CANCER RESEARCH
Citas Recibidas en Web of Science: 35
Documentos
- No hay documentos
Filiaciones
Campos de Estudio
Cita
Nagler A,Labopin M,Dholaria B,Angelucci E,Afanasyev B,Cornelissen JJ,Sica S,Meijer E,Ciceri F,Van G,Kröger N,Martin H,Pioltelli P,Risitano A,Canaani J,Savani BN,SANZ J,Mohty M. Comparison of Haploidentical Bone Marrow versus Matched Unrelated Donor Peripheral Blood Stem Cell Transplantation with Post-transplant Cyclophosphamide in Patients with Acute Leukemia. Clin. Cancer Res. 2020. 27. (3):p. 843-851. IF:12,531. (1).
Portal de investigación